A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy
Sculier, J.P., Berghmans, T., Lafitte, J.J., Richez, M., Recloux, P., Van Cutsem, O., Ninane, V., Mommen, P., Paesmans, M., Klastersky, J.Том:
37
Мова:
english
Журнал:
Lung Cancer
DOI:
10.1016/s0169-5002(02)00037-5
Date:
July, 2002
Файл:
PDF, 98 KB
english, 2002
File converter
Більше результатів пошуку
More benefits 
